{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:09:47Z","timestamp":1794344987281,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T00:00:00Z","timestamp":1447977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Health, Labor and Welfare in Japan \u201cDevelopment of Clinical Research Fellowship\u201d","award":["H21-007"],"award-info":[{"award-number":["H21-007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10157-015-1200-5","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T08:27:03Z","timestamp":1448008023000},"page":"712-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis"],"prefix":"10.1007","volume":"20","author":[{"given":"Masashi","family":"Iwabuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaya","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Oe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinobu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Taguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"issue":"1","key":"1200_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1\u201311.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1200_CR2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2215\/CJN.01461005","volume":"1","author":"S Fujimoto","year":"2006","unstructured":"Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1(5):1016\u201322.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"1200_CR3","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","volume":"23","author":"RA Watts","year":"2008","unstructured":"Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, et al. Renal vasculitis in Japan and the UK\u2013are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant. 2008;23(12):3928\u201331.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1200_CR4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","volume":"50","author":"S Fujimoto","year":"2011","unstructured":"Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology. 2011;50(10):1916\u201320.","journal-title":"Rheumatology."},{"issue":"5","key":"1200_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM197908023010503","volume":"301","author":"AS Fauci","year":"1979","unstructured":"Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979;301(5):235\u20138.","journal-title":"N Engl J Med"},{"issue":"10","key":"1200_CR6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K Groot de","year":"2009","unstructured":"de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150(10):670\u201380.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1200_CR7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","volume":"71","author":"L Harper","year":"2012","unstructured":"Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2012;71(6):955\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1200_CR8","first-page":"509","volume":"53","author":"Guidelines for the treatment of rapidly progressive glomerulonephritis","year":"2011","unstructured":"Guidelines for the treatment of rapidly progressive glomerulonephritis. Second version. Nihon Jinzo Gakkai Shi. 2011;53(4):509\u201355.","journal-title":"Nihon Jinzo Gakkai Shi"},{"issue":"4","key":"1200_CR9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s10157-012-0598-2","volume":"16","author":"K Yamagata","year":"2012","unstructured":"Yamagata K, Usui J, Saito C, Yamaguchi N, Hirayama K, Mase K, et al. ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol. 2012;16(4):580\u20138.","journal-title":"Clin Exp Nephrol"},{"key":"1200_CR10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10157-009-0201-7","volume":"13","author":"A Koyama","year":"2009","unstructured":"Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633\u201350.","journal-title":"Clin Exp Nephrol."},{"issue":"11","key":"1200_CR11","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671\u20138.","journal-title":"QJM"},{"issue":"3","key":"1200_CR12","first-page":"283","volume":"66","author":"O Flossmann","year":"2007","unstructured":"Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis. 2007;66(3):283\u201392.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1200_CR13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"1200_CR14","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628\u201336.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1200_CR15","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000286346","volume":"115","author":"M Itabashi","year":"2010","unstructured":"Itabashi M, Takei T, Yabuki Y, Suzuki H, Ando M, Akamatsu M, et al. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan. Nephron Clin Pract. 2010;115(1):c21\u20137.","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"1200_CR16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1200_CR17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","volume":"90","author":"D Adu","year":"1997","unstructured":"Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM. 1997;90(6):401\u20139.","journal-title":"QJM"},{"issue":"10","key":"1200_CR18","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","volume":"16","author":"K Groot de","year":"2001","unstructured":"de Groot K, Adu D, Savage CO. Euvas. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant. 2001;16(10):2018\u201327.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1200_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","volume":"7","author":"SL Hogan","year":"1996","unstructured":"Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):23\u201332.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"1200_CR20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K Groot De","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52(8):2461\u20139.","journal-title":"Arthritis Rheum"},{"key":"1200_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2369-14-125","volume":"14","author":"T Iwakiri","year":"2013","unstructured":"Iwakiri T, Fujimoto S, Kitagawa K, Furuichi K, Yamahana J, Matsuura Y, et al. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol. 2013;14:125.","journal-title":"BMC Nephrol"},{"issue":"3","key":"1200_CR22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1200_CR23","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4550","volume":"16","author":"KE Sada","year":"2014","unstructured":"Sada KE, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014;16(2):R101.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1200_CR24","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53(12):2306\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1200_CR25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","volume":"22","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, Atsumi T, Hayashi T, Ishizu A, Kobayashi S, Kumagai S, et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol. 2012;22(3):394\u2013404.","journal-title":"Mod Rheumatol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1200-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-015-1200-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1200-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1200-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T17:20:57Z","timestamp":1653585657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-015-1200-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1007\/s10157-015-1200-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}